Consumers’ Desire towards Current and Prospective Reproductive Genetic Testing
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
As our knowledge and abilities in molecular genetics continues to expand, so does our ability to detect certain conditions/traits prenatally; however, it is unknown if this increase in scientific ability will be utilized by the consumers of genetic services. Our study gauges the consumers’ opinion towards reproductive testing for diseases and enhancements. Prior to their initial visit with a genetic counselor, patients were asked to participate in a survey. These consumers were asked to indicate traits and conditions for which they would choose reproductive genetic testing. The majority of respondents would elect to have prenatal genetic testing for mental retardation (75%), deafness (54%), blindness (56%), heart disease (52%), and cancer (51%). Our results indicated that 49.3% would choose testing for a condition that resulted in death by 5 years of age, whereas only 41.1%, 24.9%, and 19% would choose testing for conditions that results in death by 20, 40, and 50 years of age, respectively. Most respondents did not desire testing for enhancements (e.g. 13% would choose testing for superior intelligence). Our study suggests that consumers desire more reproductive genetic testing than what is currently offered; however, their selection of tests suggests self-imposed limits on testing.
- Alsulaiman, A., & Hewison, J. (2007). Attitudes to prenatal testing and termination of pregnancy in Saudi Arabia. Community Genetics, 10(3), 169–173. doi:10.1159/000101758. CrossRef
- Anido, A., Carlson, L. M., Taft, L., & Sherman, S. L. (2005). Women’s attitude toward testing for Fragile X carrier status: a qualitative analysis. Journal of Genetic Counseling, 14(4), 295–306. doi:10.1007/s10897-005-1159-6. CrossRef
- Austin, J., Smith, G., & Honer, W. (2006). The genomic era and perceptions of psychotic disorders: genetic risk estimation, associations with reproductive decisions and views about predictive testing. American Journal of Medical Genetics, 141B, 926–928. doi:10.1002/ajmg.b.30372. CrossRef
- Boué, J., Muller, F., Simon-Bouy, B., Faure, C., & Boué, A. (1991). Consequences of prenatal diagnosis of cystic fibrosis on the reproductive attitudes of parents of affected children. Prenatal Diagnosis, 11, 209–214. doi:10.1002/pd.1970110402. CrossRef
- Brunger, J. W., Murray, G. S., O’Riordan, M., Matthews, A. L., Smith, R. J., & Robin, N. H. (2000). Parental attitudes toward genetic testing for pediatric deafness. American Journal of Human Genetics, 67(6), 1621–1625, Dec. CrossRef
- Campbell, E., & Ross, L. F. (2004). Attitudes of healthcare professionals and parents regarding genetic testing for violent traits in childhood. Journal of Medical Ethics, 30(6), 580–586. doi:10.1136/jme.2003.005389. CrossRef
- Case, A., Ramadhani, T. A., Canfield, M. A., & Wicklund, C. A. (2007). Awareness and attitudes regarding prenatal testing among Texas women of childbearing age. Journal of Genetic Counseling, 16(5), 551–664. doi:10.1007/s10897-007-9103-6. CrossRef
- Conway, S. P., Allenby, K., & Pond, M. N. (1994). Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre. Clinical Genetics, 45, 308–312. CrossRef
- Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., et al. (2003). Predictive, pre-natal and diagnostic testing for Huntington disease: the experience in Canada from 1987–2000. Clinical Genetics, 63, 462–475. doi:10.1034/j.1399-0004.2003.00093.x. CrossRef
- Dyson, F. (2007). Our biotech future. The New York Review of Books, 54, 4–8.
- Eng, C. M., et al. (1997). Prenatal genetic carrier testing using triple disease screening. Journal of the American Medical Association, 278(15), 1268–1272. doi:10.1001/jama.278.15.1268. CrossRef
- Gason, A. A., et al. (2003). Evaluation of a Tay Sachs Disease Screening Program. Clinical Genetics, 63(5), 386–392. doi:10.1034/j.1399-0004.2003.00074.x. CrossRef
- Harmon, A. (2004a). As gene test menu grows, who gets to choose? The New York Times, July 21.
- Harmon, A. (2004b). Burden of knowledge: tracking prenatal health; In New Tests for Fetal Defects, Agonizing Choices for Parents. The New York Times, June 20.
- Harmon, A. (2004c) Neurodiversity forever; the disability movement turns to brains. The New York Times, May 9.
- Harmon, A. (2005). The problem with an almost perfect genetic world. The New York Times, November 20.
- Hayden, M. R. (2000). Predictive testing for Huntington disease: the calm after the storm. Lancet, 356, 1944–1945. doi:10.1016/S0140-6736(00)03301-8. CrossRef
- Henneman, L., et al. (2001). Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenatal Diagnosis, 21(1), 1–9. doi:10.1002/1097-0223(200101)21:1<1::AID-PD9671::AID-PD967>3.0.CO;2-#. CrossRef
- Hewison, J., et al. (2007). Attitudes to prenatal testing and termination of pregnancy for fetal abnormality: a comparison of white and Pakistani women in the UK. Prenatal Diagnosis, 27(5), 419–430. doi:10.1002/pd.1701. CrossRef
- Hudson, K., et al. (2004). Reproductive genetic testing: what America thinks. Genetics and Public Policy Center. Available at: http://www.dnapolicy.org/pub.reports.php?action=detail&report_id=6 Accessed May 20, 2007.
- Jones, I., Scourfield, J., McCandless, F., & Craddock, N. (2002). Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. Journal of Affective Disorders, 71, 189–193. doi:10.1016/S0165-0327(00)00384-0. CrossRef
- Kessler, S., Field, T., Worth, L., & Mosbarger, H. (1987). Attitudes of persons at risk for Huntington disease toward predictive testing. American Journal of Medical Genetics, 26, 259–270. doi:10.1002/ajmg.1320260204. CrossRef
- Kronn, D., Jansen, V., & Ostrer, H. (1998). Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Archives of Internal Medicine, 158(7), 777–781. CrossRef
- Lima, M., Kay, T., Vasconcelos, J., et al. (2001). Disease knowledge and attitudes toward predictive testing and prenatal diagnosis in families with Machado–Joseph disease from Azores Islands (Portugal). Community Genetics, 4(1), 36–42. doi:10.1159/000051154. CrossRef
- Markel, D. S., Young, A. B., & Penney, J. B. (1987). At-risk persons’ attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. American Journal of Medical Genetics, 26, 295–305. doi:10.1002/ajmg.1320260207. CrossRef
- Mastromauro, C., Myers, R. H., & Berkman, B. (1987). Attitudes toward presymptomatic testing in Huntington disease. American Journal of Medical Genetics, 26, 271–282. doi:10.1002/ajmg.1320260205. CrossRef
- Meissen, G. J., & Berchek, R. L. (1987). Intended use of predictive testing by those at risk for Huntington disease. American Journal of Medical Genetics, 26, 283–293. doi:10.1002/ajmg.1320260206. CrossRef
- Milner, K., Collins, E., Connors, G., & Petty, E. (1998). Attitudes of young adults to prenatal screening and genetic correction for human attributes and psychiatric conditions. American Journal of Medical Genetics, 76, 111–119. doi:10.1002/(SICI)1096-8628(19980305)76:2<111::AID-AJMG2>3.0.CO;2-W. CrossRef
- Milner, K., Han, T., & Petty, E. (1999). Support for the availability of prenatal testing for neurological and psychiatric conditions in the psychiatric community. Genetic Testing, 3(3), 279–286. doi:10.1089/109065799316590. CrossRef
- Nelkin, D., & Tancredi, L. (1989). Diagnosis in the healthcare system. In Dangerous Diagnostics: The Social Power of Biological Information (pp. 51–74). New York: Basic.
- Rothman, S., & Rothman, D. (2003). The Pursuit of Perfection: The Promise and Perils of Medical Enhancement, 1st Edn. New York: Pantheon.
- Sandel, M. J. (2007). The Case against Perfection: Ethics in the Age of Genetic Engineering, 1st Edn. Cambridge: Harvard University Press.
- Toivianen, H., Jallinoja, P., Aro, A., & Hemminki, E. (2003). Medical and lay attitudes towards genetic screening and testing in Finland. European Journal of Human Genetics, 11, 565–572. doi:10.1038/sj.ejhg.5201006. CrossRef
- U.S. Census Bureau. American Fact Finder, 2000. Available at: http://factfinder.census.gov/home/saff/main.html?_lang=en Accessed May 7, 2008.
- Watson, E. K., Marchant, J., Bush, A., & Williamson, B. (1992). Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. Journal of Medical Genetics, 29, 490.
- Consumers’ Desire towards Current and Prospective Reproductive Genetic Testing
Journal of Genetic Counseling
Volume 18, Issue 2 , pp 137-146
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Human Genetics Program, New York University School of Medicine, New York, NY, USA
- 2. New York University Clinical Cancer Center, New York, NY, USA
- 4. NYU Clinical Cancer Center, 160 East 34th St, 10th floor Room 1012, New York, NY, 10016, USA
- 3. Stern College for Women at Yeshiva University, New York, NY, USA